My-Cardia

My-Cardia is a cardiac monitoring company focused on ambulatory, non-invasive ECG event monitoring products and related cloud software. Its flagship offering, MyCardia AT, is a wearable external event recorder designed for up to 30 days of monitoring and can capture both patient-activated and asymptomatic rhythm events using an auto-trigger algorithm. The company also provides smartphone-enabled transmission and a cloud-based web portal for report access and workflow management, particularly for international users. My-Cardia appears to operate both as a standalone brand and as the name of Cardiac Biotech Solutions' wholly owned U.S. subsidiary, My-Cardia (USA), Inc. The business is commercial-stage and focused on cardiology diagnostics rather than drug development.